MSBEarnings•globenewswire•
Banner Year for Mesoblast With First FDA Product Approval and Successful Commercial Launch of Ryoncil®
Sentiment:Positive (85)
Summary
(NYSE:MSB) Financial Results and Operational Update for the Full Year Ended June 30, 2025 Financial Results and Operational Update for the Full Year Ended June 30, 2025
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 29, 2025 by globenewswire